☰

Wolf Mueller - Publications

Affiliations: 
Neuropathology Ruprecht-Karls-University Heidelberg, Heidelberg, Baden-Württemberg, Germany 
Website:
http://www.medicalnewstoday.com/articles/162605.php
Tree Info Grants Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Muench A, Teichmann D, Spille D, Kuzman P, Perez E, May SA, Mueller WC, Kombos T, Nazari-Dehkordi S, Onken J, Vajkoczy P, Ntoulias G, Bettencourt C, von Deimling A, Paulus W, et al. A Novel Type of IDH Wild-type Glioma Characterized by Gliomatosis Cerebri-like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile. The American Journal of Surgical Pathology. PMID 37737691 DOI: 10.1097/PAS.0000000000002118  0.303
2021 Sievers P, Henneken SC, Blume C, Sill M, Schrimpf D, Stichel D, Okonechnikov K, Reuss DE, Benzel J, Maaß KK, Kool M, Sturm D, Zheng T, Ghasemi DR, Kohlhof-Meinecke P, ... ... Mueller WC, et al. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors. Acta Neuropathologica. PMID 34355256 DOI: 10.1007/s00401-021-02356-6  0.327
2020 Wallenborn M, Xu LX, Kirsten H, Rohani L, Rudolf D, Ahnert P, Schmidt C, Schulz RM, Richter M, Krupp W, Mueller W, Johnson AA, Meixensberger J, Holland H. Molecular analyses of glioblastoma stem-like cells and glioblastoma tissue. Plos One. 15: e0234986. PMID 32634135 DOI: 10.1371/Journal.Pone.0234986  0.412
2018 Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, Huang K, Wefers AK, Hovestadt V, Sill M, Gramatzki D, Felsberg J, Reifenberger G, Koch A, ... ... Mueller W, et al. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica. PMID 29564591 DOI: 10.1007/S00401-018-1837-8  0.698
2018 Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, ... ... Mueller W, et al. DNA methylation-based classification of central nervous system tumours. Nature. PMID 29539639 DOI: 10.1038/Nature26000  0.632
2016 Drachsler M, Kleber S, Mateos A, Volk K, Mohr N, Chen S, Cirovic B, Tüttenberg J, Gieffers C, Sykora J, Wirtz CR, Mueller W, Synowitz M, Martin-Villalba A. CD95 maintains stem cell-like and non-classical EMT programs in primary human glioblastoma cells. Cell Death & Disease. 7: e2209. PMID 27124583 DOI: 10.1038/Cddis.2016.102  0.334
2016 Kratz A, Sahm F, Schrimpf D, Jones DT, Reuß D, Kölsche C, Huang K, Wefers AK, Hovestadt V, Gramatzki D, Felsberg J, Koch A, Thomale UW, Reifenberger G, Becker A, ... ... Mueller W, et al. HG-68COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA Neuro-Oncology. 18: iii63.2-iii63. DOI: 10.1093/Neuonc/Now073.64  0.628
2015 Xu LX, Holland H, Kirsten H, Ahnert P, Krupp W, Bauer M, Schober R, Mueller W, Fritzsch D, Meixensberger J, Koschny R. Three gangliogliomas: results of GTG-banding, SKY, genome-wide high resolution SNP-array, gene expression and review of the literature. Neuropathology : Official Journal of the Japanese Society of Neuropathology. 35: 148-57. PMID 25376146 DOI: 10.1111/Neup.12176  0.412
2014 Sahm F, Reuss D, Koelsche C, Capper D, Schittenhelm J, Heim S, Jones DT, Pfister SM, Herold-Mende C, Wick W, Mueller W, Hartmann C, Paulus W, von Deimling A. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathologica. 128: 551-9. PMID 25143301 DOI: 10.1007/S00401-014-1326-7  0.562
2014 Sahm F, Reuss D, Koelsche C, Capper D, Schittenhelm J, Heim S, Herold-Mende C, Wick W, Mueller W, Hartmann C, Paulus W, Deimling Av. Ge-30Oligoastrocytoma Does Not Exist: In-Situ Molecular Genetics Favors Classification As Either Oligodendroglioma Or Astrocytoma Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou256.29  0.423
2013 Sahm F, Lass U, Herold-Mende C, von Deimling A, Hartmann C, Mueller W. Analysis of CIC-associated CpG island methylation in oligoastrocytoma. Neuropathology and Applied Neurobiology. 39: 831-6. PMID 23521081 DOI: 10.1111/Nan.12045  0.565
2013 Lass U, Hartmann C, Capper D, Herold-Mende C, von Deimling A, Meiboom M, Mueller W. Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain Pathology (Zurich, Switzerland). 23: 311-8. PMID 23107103 DOI: 10.1111/bpa.12003  0.435
2012 Lass U, Nümann A, von Eckardstein K, Kiwit J, Stockhammer F, Horaczek JA, Veelken J, Herold-Mende C, Jeuken J, von Deimling A, Mueller W. Clonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1- mutation as common tumor initiating event. Plos One. 7: e41298. PMID 22844452 DOI: 10.1371/journal.pone.0041298  0.364
2012 Meiri E, Mueller WC, Rosenwald S, Zepeniuk M, Klinke E, Edmonston TB, Werner M, Lass U, Barshack I, Feinmesser M, Huszar M, Fogt F, Ashkenazi K, Sanden M, Goren E, et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. The Oncologist. 17: 801-12. PMID 22618571 DOI: 10.1158/Diag-10-A28  0.378
2012 Sahm F, Koelsche C, Meyer J, Pusch S, Lindenberg K, Mueller W, Herold-Mende C, von Deimling A, Hartmann C. CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathologica. 123: 853-60. PMID 22588899 DOI: 10.1007/S00401-012-0993-5  0.567
2011 Rosenwald S, Edmonston T, Barshack I, Feinmesser M, Huszar M, Mueller W, Fogt F, Spector Y, Aharonov R, Meiri E. Abstract 1148: Development and validation of a second generation microRNA-based assay for diagnosing tumor tissue origin Cancer Research. 71: 1148-1148. DOI: 10.1158/1538-7445.Am2011-1148  0.385
2010 Meyer J, Pusch S, Balss J, Capper D, Mueller W, Christians A, Hartmann C, von Deimling A. PCR- and restriction endonuclease-based detection of IDH1 mutations. Brain Pathology (Zurich, Switzerland). 20: 298-300. PMID 19744125 DOI: 10.1111/J.1750-3639.2009.00327.X  0.527
2009 Elias A, Siegelin MD, Steinmüller A, von Deimling A, Lass U, Korn B, Mueller W. Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5457-65. PMID 19706813 DOI: 10.1158/1078-0432.Ccr-09-1125  0.332
2009 Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken JW, Wesseling P, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathologica. 118: 469-74. PMID 19554337 DOI: 10.1007/S00401-009-0561-9  0.549
2009 Mogler C, Kohlhof P, Penzel R, Grenacher L, Haag GM, Schirmacher P, Mueller W. A primary malignant ependymoma of the abdominal cavity: a case report and review of the literature. Virchows Archiv : An International Journal of Pathology. 454: 475-8. PMID 19238432 DOI: 10.1007/S00428-009-0744-8  0.365
2009 Capper D, Gaiser T, Hartmann C, Habel A, Mueller W, Herold-Mende C, von Deimling A, Siegelin MD. Stem-cell-like glioma cells are resistant to TRAIL/Apo2L and exhibit down-regulation of caspase-8 by promoter methylation. Acta Neuropathologica. 117: 445-56. PMID 19214542 DOI: 10.1007/s00401-009-0494-3  0.377
2009 Lorente A, Mueller W, Urdangarín E, Lázcoz P, Lass U, von Deimling A, Castresana JS. RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs. Brain Pathology (Zurich, Switzerland). 19: 279-92. PMID 18616639 DOI: 10.1111/J.1750-3639.2008.00185.X  0.42
2008 Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathologica. 116: 597-602. PMID 18985363 DOI: 10.1007/S00401-008-0455-2  0.576
2008 Posch MG, Posch MJ, Geier C, Erdmann B, Mueller W, Richter A, Ruppert V, Pankuweit S, Maisch B, Perrot A, Buttgereit J, Dietz R, Haverkamp W, Ozcelik C. A missense variant in desmoglein-2 predisposes to dilated cardiomyopathy. Molecular Genetics and Metabolism. 95: 74-80. PMID 18678517 DOI: 10.1016/J.Ymgme.2008.06.005  0.315
2008 Lorente A, Mueller W, Urdangarín E, Lázcoz P, von Deimling A, Castresana JS. Detection of methylation in promoter sequences by melting curve analysis-based semiquantitative real time PCR. Bmc Cancer. 8: 61. PMID 18298842 DOI: 10.1186/1471-2407-8-61  0.318
2007 Mueller W, Nutt CL, Ehrich M, Riemenschneider MJ, von Deimling A, van den Boom D, Louis DN. Downregulation of RUNX3 and TES by hypermethylation in glioblastoma. Oncogene. 26: 583-93. PMID 16909125 DOI: 10.1038/Sj.Onc.1209805  0.698
2006 Hunter C, Smith R, Cahill DP, Stephens P, Stevens C, Teague J, Greenman C, Edkins S, Bignell G, Davies H, O'Meara S, Parker A, Avis T, Barthorpe S, Brackenbury L, ... ... Mueller W, et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Research. 66: 3987-91. PMID 16618716 DOI: 10.1158/0008-5472.Can-06-0127  0.637
2006 Mueller W, Lass U, Veelken J, Reuter F, von Deimling A. 45-year-old male with symptomatic mass in the frontal lobe. Brain Pathology (Zurich, Switzerland). 16: 89-90, 93. PMID 16612988 DOI: 10.1111/j.1750-3639.2006.tb00567.x  0.3
2005 Riemenschneider MJ, Mueller W, Betensky RA, Mohapatra G, Louis DN. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation. The American Journal of Pathology. 167: 1379-87. PMID 16251422 DOI: 10.1016/S0002-9440(10)61225-4  0.498
2005 Mueller W, Mizoguchi M, Silen E, D'Amore K, Nutt CL, Louis DN. Mutations of the PIK3CA gene are rare in human glioblastoma. Acta Neuropathologica. 109: 654-5. PMID 15924252 DOI: 10.1007/S00401-005-1001-0  0.726
2005 Hartmann C, Mueller W, Lass U, Kamel-Reid S, von Deimling A. Molecular genetic analysis of oligodendroglial tumors. Journal of Neuropathology and Experimental Neurology. 64: 10-4. PMID 15715080 DOI: 10.1093/Jnen/64.1.10  0.474
2005 Mueller W, Lass U, Wellmann S, Kunitz F, von Deimling A. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas. Acta Neuropathologica. 109: 314-20. PMID 15668788 DOI: 10.1007/S00401-004-0969-1  0.367
2004 Hartmann C, Mueller W, von Deimling A. Pathology and molecular genetics of oligodendroglial tumors. Journal of Molecular Medicine (Berlin, Germany). 82: 638-55. PMID 15322700 DOI: 10.1007/S00109-004-0565-9  0.492
2004 Mueller W, Eum JH, Lass U, Paulus W, Sarkar C, Bruck W, von Deimling A. No evidence of hSNF5/INI1 point mutations in choroid plexus papilloma. Neuropathology and Applied Neurobiology. 30: 304-7. PMID 15175083 DOI: 10.1046/J.0305-1846.2004.00538.X  0.4
2004 Hartmann C, Nümann A, Mueller W, Holtkamp N, Simon M, von Deimling A. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. International Journal of Cancer. Journal International Du Cancer. 108: 839-44. PMID 14712485 DOI: 10.1002/Ijc.11638  0.582
2003 Hartmann C, Mueller W, Lass U, Stockhammer F, von Eckardstein K, Veelken J, Jeuken J, Wick W, von Deimling A. No preferential loss of paternal 19q alleles in oligodendroglial tumors. Annals of Neurology. 54: 256-8. PMID 12891681 DOI: 10.1002/Ana.10649  0.517
2002 Mueller W, Mollenhauer J, Stockhammer F, Poustka A, von Deimling A. Rare mutations of the DMBT1 gene in human astrocytic gliomas. Oncogene. 21: 5956-9. PMID 12185598 DOI: 10.1038/Sj.Onc.1205733  0.471
2002 Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. The American Journal of Pathology. 161: 313-9. PMID 12107116 DOI: 10.1016/S0002-9440(10)64183-1  0.643
2002 Schmidt MC, Antweiler S, Urban N, Mueller W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R, von Deimling A. Impact of genotype and morphology on the prognosis of glioblastoma. Journal of Neuropathology and Experimental Neurology. 61: 321-8. PMID 11939587 DOI: 10.1093/Jnen/61.4.321  0.52
2001 Kroppenstedt SN, Liebig T, Mueller W, Gräf KJ, Lanksch WR, Unterberg AW. Secondary abscess formation in pituitary adenoma after tooth extraction. Case report. Journal of Neurosurgery. 94: 335-8. PMID 11213976 DOI: 10.3171/Jns.2001.94.2.0335  0.314
2001 Schmitz U, Mueller W, Weber M, Sévenet N, Delattre O, von Deimling A. INI1 mutations in meningiomas at a potential hotspot in exon 9. British Journal of Cancer. 84: 199-201. PMID 11161377 DOI: 10.1054/Bjoc.2000.1583  0.435
2001 Mueller W, Lass U, Herms J, Kuchelmeister K, Bergmann M, von Deimling A. Clonal analysis in glioblastoma with epithelial differentiation. Brain Pathology (Zurich, Switzerland). 11: 39-43. PMID 11145202 DOI: 10.1111/J.1750-3639.2001.Tb00379.X  0.33
Show low-probability matches.